Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.

Abstract

Recent studies demonstrated that dihydromyricetin (DHM) has prominent therapeutic effects on liver injury and liver cancer. By summarizing the current preclinical in vitro and in vivo studies, the present review examines the preventive and therapeutic effects of DHM on liver disorders as well as its potential mechanisms. Briefly, in both chemical- and alcohol-induced liver injury models, DHM ameliorates hepatocyte necrosis and steatosis while promoting liver regeneration. In addition, DHM can alleviate nonalcoholic fatty liver disease (NAFLD) via regulating lipid/glucose metabolism, probably due to its anti-inflammatory or sirtuins-dependent mechanisms. Furthermore, DHM treatment inhibits cell proliferation, induces apoptosis and autophagy and regulates redox balance in liver cancer cells, thus exhibiting remarkable anti-cancer effects. The pharmacological mechanisms of DHM may be associated with its anti-inflammatory, anti-oxidative and apoptosis-regulatory benefits. With the accumulating interests in utilizing natural products to target common diseases, our work aims to improve the understanding of DHM acting as a novel drug candidate for liver diseases and to accelerate its translation from bench to bedside.

• Authors: Jingnan Chen, Xitong Wang, Tian Xia, Yanhua Bi, Bin Liu, Junfen Fu, Runzhi Zhu
• Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 142 Pg. 111927 (Oct 2021) ISSN: 1950-6007 [Electronic] France
• PMID: 34339914 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Chemical References

• Flavonols
• Protective Agents
• dihydromyricetin

Topics

• Carcinoma, Hepatocellular (metabolism, prevention & control)
• Flavonols (pharmacokinetics, pharmacology, therapeutic use)
• Humans
• Liver Diseases (metabolism, prevention & control)
• Liver Diseases, Alcoholic (metabolism, prevention & control)
• Liver Failure, Acute (metabolism, prevention & control)
• Liver Neoplasms (metabolism, prevention & control)
• Liver Regeneration (drug effects)
• Non-alcoholic Fatty Liver Disease (metabolism, prevention & control)
• Protective Agents (pharmacokinetics, pharmacology, therapeutic use)